Overview

Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)

Status:
Completed
Trial end date:
2006-11-21
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine if the co-administration of formoterol fumarate and tiotropium bromide is more effective than the use of tiotropium bromide alone in patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborators:
Integrated Therapeutics Group
Novartis
Treatments:
Bromides
Formoterol Fumarate
Tiotropium Bromide